Therapure Biopharma Inc. Files Preliminary Prospectus for Initial Public Offering

MISSISSAUGA, Ontario–(BUSINESS WIRE)–Therapure Biopharma Inc. today announces that it has filed a preliminary prospectus with securities regulatory authorities in each of the provinces and territories of Canada in connection with a proposed initial public offering (the “Offering”) of its common shares. A copy of the preliminary prospectus is available on SEDAR ( The Offering is being made through a syndicate of underwriters co-led by GMP Securities L.P., CIBC World Markets Inc.


Print Friendly, PDF & Email

Share This

Share this post with your friends!